Patient-Specific Polyvinyl Alcohol Phantom Fabrication with Ultrasound and X-Ray Contrast for Brain Tumor Surgery Planning
July 14th, 2020
9.6K views
This protocol describes the fabrication of a patient specific skull, brain and tumor phantom. It uses 3D printing to create molds, and polyvinyl alcohol (PVA-c) is used as the tissue mimicking material.
Overview
This protocol describes the fabrication of a patient-specific skull, brain, and tumor phantom using 3D printing techniques. It emphasizes the importance of anatomical accuracy in phantom models for surgical planning and clinical training.
Key Study Components
Area of Science
- Neuroscience
- Biomedical Engineering
- 3D Printing
Background
- Phantom models are crucial for simulating surgical scenarios.
- Creating anatomically accurate models is challenging but essential.
- Patient-specific phantoms enhance the realism of surgical training.
- 3D printing allows for precise customization based on patient data.
Purpose of Study
- To develop a method for creating realistic brain and tumor phantoms.
- To facilitate surgical planning and instrument testing.
- To improve clinical training through enhanced anatomical models.
Methods Used
- Utilization of CT and MRI data for model creation.
- 3D modeling software to design and manipulate anatomical structures.
- 3D printing of molds using polylactic acid and PVA.
- Preparation of tissue-mimicking materials for realistic phantoms.
Main Results
- Successfully fabricated a patient-specific skull, brain, and tumor model.
- Achieved high anatomical realism in the phantom structures.
- Demonstrated the effectiveness of the 3D printing process.
- Provided a detailed protocol for replicating the process.
Conclusions
- The developed protocol allows for the creation of anatomically accurate phantoms.
- Patient-specific models can significantly enhance surgical training.
- 3D printing is a viable method for producing complex anatomical structures.
Frequently Asked Questions
What materials are used in the phantom fabrication?
The protocol uses polylactic acid for molds and polyvinyl alcohol (PVA) as the tissue-mimicking material.
How does the 3D printing process work?
3D printing involves creating molds from STL files and using a rigid material to print the anatomical structures.
What imaging techniques are utilized?
CT and MRI data are used to create patient-specific models for the phantoms.
Why are patient-specific phantoms important?
They allow for better surgical planning, instrument testing, and clinical training by providing realistic anatomical representations.
What is the significance of the freeze-thaw cycle?
The freeze-thaw cycle helps in solidifying the PVA and ensuring the structural integrity of the phantom models.
Can the protocol be adapted for other anatomical structures?
Yes, the methods can be modified to create phantoms for various anatomical structures based on specific needs.
Executive Industry Relevance
Patient-specific anatomical phantoms enable preclinical validation of neurosurgical navigation systems and intraoperative imaging tools, reducing biological risk in early-stage device development. By replicating patient-specific tumor contrast under ultrasound and X-ray, the method supports mechanistic de-risking of image-guided interventions prior to first-in-human studies. This capability enhances predictive confidence in targeting accuracy and tissue interaction profiles during discovery-stage validation.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables hypothesis testing of navigation accuracy in patient-specific anatomical contexts.
- Operational Value: Provides reproducible tumor models with defined ultrasound and X-ray contrast for controlled intervention studies.
Screening & Assay Development
- Scientific Value: Standardizes phantom tissue properties to support quantitative assessment of device-tissue interactions.
- Operational Value: Uses scalable 3D-printed molds and freeze-thaw PVA processing for batch production of imaging-validated phantoms.
Translational & Preclinical Research
- Scientific Value: Maintains anatomical fidelity from patient imaging to physical model, supporting translational continuity in neurosurgical workflows.
- Operational Value: Allows direct comparison of intraoperative ultrasound data between phantom and patient, validating imaging fidelity in a reusable platform.
Pipeline & Workflow Integration
The method integrates into early discovery by providing anatomically accurate models for hypothesis-driven testing of navigation systems and imaging-guided interventions.
- Discovery Biology: Supports biological de-risking by enabling repeatable testing of device performance in patient-specific tumor microenvironments.
- Screening: Delivers assay-ready phantoms with standardized contrast agents for ultrasound and X-ray visualization.
- Analytics: Generates comparable imaging outputs (ultrasound brightness, X-ray attenuation) to benchmark device performance against patient data.
- Translational Research: Connects preoperative imaging to physical model, facilitating validation of navigation accuracy before preclinical survival studies.
- Enterprise Reuse: Enables sharing of 3D printing files and PVA protocols across sites for standardized neurosurgical device evaluation.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in device-tissue interaction through controlled, patient-relevant phantom testing.
- Operational Value: Ensures reproducibility via standardized material preparation (PVA concentration, freeze-thaw cycles) and mold-based fabrication.
- Strategic Value: Improves go/no-go decisions by providing quantitative imaging feedback on navigation accuracy before costly in vivo studies.
- Portfolio Impact: Supports risk-adjusted advancement of neurosurgical tools by validating targeting precision in anatomically complex, tumor-bearing models.
Implementation Considerations
- Requires expertise in 3D modeling software, segmentation of MRI/CT data, and CAD-based mold design.
- Dependent on access to 3D printers capable of processing polylactic acid and PVA support materials.
- Necessitates cross-team standardization of PVA preparation protocols (concentration, sonication, freeze-thaw cycles) for consistent phantom properties.
- Involves adaptation considerations when modifying mold geometry for different tumor locations or sizes while maintaining structural integrity.
- Limited by the need for specialized freezing equipment to achieve controlled solidification of PVA-based tumor and tissue mimics.
Biopharma FAQs
Why does ultrasound contrast matter for tumor visualization in phantom models?
The protocol adds 1% glass microspheres to the PVA tumor mimic to create off-white contrast under ultrasound, enabling differentiation from surrounding brain tissue. This allows visualization of tumor boundaries using intraoperative ultrasound data, supporting validation of navigation accuracy in image-guided surgery.
How does X-ray contrast enable CT-based validation of phantom anatomy?
5% barium sulfate is incorporated into the tumor-mimicking PVA to provide X-ray attenuation, making the tumor visible in CT scans of the phantom. This allows comparison with preoperative contrast-enhanced CT data to validate anatomical fidelity of the printed skull, brain, and tumor structures.
What quantitative measurements enable assessment of navigation system accuracy?
The method supports comparison of intraoperative ultrasound images from the phantom with patient-specific ultrasound data, allowing quantitative assessment of signal intensity and spatial registration. These measurements help determine targeting error and confidence in device guidance during simulated tumor resection.
Why are replication requirements critical for cross-functional collaboration in device testing?
The freeze-thaw cycle is repeated twice to ensure consistent structural integrity and material properties across phantom replicates, reducing variability in mechanical and imaging responses. This standardization enables reliable sharing of 3D-printed molds and PVA protocols between research, engineering, and preclinical teams.
What statistical analysis capabilities are required before implementing this phantom in preclinical workflows?
Implementation requires the ability to compare ultrasound grayscale values and CT Hounsfield units between phantom and patient images to quantify contrast fidelity and anatomical deviation. These analyses support go/no-go decisions by establishing predefined thresholds for acceptable navigation error in targeting studies.
